✦ LIBER ✦

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

✍ Scribed by Edward Snyder; Jeffrey McCullough; Sherrill J. Slichter; Ronald G. Strauss; Ileana Lopez-Plaza; Jin-Sying Lin; Laurence Corash; Maureen G. Conlan; SPRINT Study Group

Book ID: 109142926
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 103 KB
Volume: 45
Category: Article
ISSN: 0372-1248
DOI: 10.1111/j.1537-2995.2005.00639.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pathogen inactivation of platelets with

Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial

✍ Alvaro Pineda; Jeffrey McCullough; Richard J. Benjamin; Ritchard Cable; Ronald G 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Platelet dose consistency and its effect

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

✍ Scott Murphy; Edward Snyder; Ritchard Cable; Sherrill J. Slichter; Ronald G. Str 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Photochemical treatment of platelet conc

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

✍ Lily Lin; Roberta Dikeman; Barbara Molini; Sheila A. Lukehart; Robert Lane; Kent 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

The efficacy of photochemical treatment

The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets

✍ Emma Castro; Nuria Gironés; José Luis Bueno; Javier Carrión; Lily Lin; Manuel Fr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 237 KB

A multi-centre study of therapeutic effi

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

✍ Miguel Lozano; Folke Knutson; René Tardivel; Joan Cid; Rosa Maria Maymó; Helena 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

A randomized controlled clinical trial e

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

✍ J-P. Cazenave; G. Folléa; L. Bardiaux; J.-M. Boiron; B. Lafeuillade; M. Debost; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 344 KB